# Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)

> **NCT06111183** · PHASE2 · COMPLETED · sponsor: **Aurealis Oy** · enrollment: 64 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **BIOLOGICAL:** AUP1602-C
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06111183
- **Lead sponsor:** Aurealis Oy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-21
- **Primary completion:** 2025-11-28
- **Final completion:** 2025-11-28
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111183, "Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06111183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*